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Announcements1
EMPLOYMENT OPPORTUNITIES
Population Genetics Faculty Position.—A tenure-track
assistant professor position in population genetics will
be available beginning in August, 2003, in the Depart-
ment of Biological and Physical Sciences at Kennesaw
State University. Preference will be given to applicants
with demonstrated excellence in teaching at the college
level. Applicants should have postdoctoral research ex-
perience and a strong potential for developing an ex-
ternally funded research program involving undergrad-
uates. An earned doctorate in an appropriate discipline
is required. Review of applications will commence on
November 1, 2002, and will continue until the position
is filled. Submit a letter describing qualifications for the
position, a statement of teaching philosophy, a statement
of research interests, a current curriculum vitae, graduate
transcripts, and the names, addresses, telephone num-
bers, and e-mail addresses of three references to Dr. Dale
Lynn Vogelien, Population Genetics Search Committee,
Department of Biological and Physical Sciences, #1202,
Kennesaw State University, 1000 Chastain Road, Ken-
nesaw, GA 30144-5591; e-mail: dvogelie@kennesaw
.edu. Kennesaw State University is an affirmative action/
equal opportunity employer. Women and minorities are
encouraged to apply.
Medical Director.—Quest Diagnostics, Inc., is a Fortune
500 company and the worldwide leader in providing
1. Announcements are published free of charge for members of The
American Society of Human Genetics (ASHG). Please mail announce-
ments to The American Journal of Human Genetics, Department of
Human Genetics, Emory University School of Medicine, 615 Michael
Street, Room 301, Atlanta, GA 30322-3050; fax them to (404) 712-
9984; or send via E-mail to ajhg@emory.edu. Submission must be
received at least 7 weeks before the month of issue in which publication
is requested. They must be double spaced with a -inch margin on112
all sides. The maximum length is 250 words, excluding the address
for correspondence. Please include a cover letter indicating the name
of the sponsoring ASHG member.
clinical diagnostic services to physicians, hospitals, and
managed care organizations. We have a busy biochem-
ical genetics laboratory using high-performance liquid
chromatography, GC-MS, amino acid analyzers, LC-
MS/MS, and several automated analysis platforms. The
medical director is directly responsible for medical in-
terpretations and consultations and, as the leader of the
laboratory, is indirectly responsible for all aspects of lab-
oratory operations, R&D, compliance, and quality as-
surance. Candidates must have an M.D. degree and will
be expected to obtain a California medical license. Board
certification or eligibility in biochemical genetics from
the American Board of Medical Genetics is also required.
Good verbal and written communication skills, as well
as good decision-making capabilities, are required. En-
joy the Southern California lifestyle with interesting
cases and colleagues! Quest Diagnostics, Inc., offers a
competitive compensation and an excellent benefits
package. For immediate consideration, please send your
re´sume´, with salary history and requirements, to Quest
Diagnostics, Inc., Attn: Charles M. Strom, M.D., Ph.D.,
Medical Director, Genetics, 33608 Ortega Highway, San
Juan Capistrano, CA 92690-6130; e-mail: Charles.M
.Strom@questdiagnostics.com. Electronic inquiries are
encouraged.
Neel Distinguished Chair in Biotechnology.—The De-
partment of Biological and Physical Sciences at Ken-
nesaw State University is accepting applications for the
Holmes Neel Distinguished Chair in Biotechnology,
available August, 2003. The successful candidate will
be expected to provide leadership for a recently ap-
proved baccalaureate program in biotechnology and to
develop collaborations with local biotechnology in-
dustry partners. Minimum qualifications are a Ph.D. in
biology or a related field, a demonstrated ability to
develop a multidisciplinary research program in an area
related to biotechnology, and a record of sustained ex-
tramural funding. Review of applications will com-
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mence on November 1, 2002, and will continue until
the position is filled. Submit a letter describing your
qualifications for the position, a statement of research
interests, a plan for interacting with the local biotech-
nology community, a current curriculum vitae, grad-
uate transcripts, and the names, addresses, telephone
numbers, and e-mail addresses of three references to
Dr. Kathleen Fleiszar, Neel Distinguished Chair Search
Committee, Department of Biological and Physical Sci-
ences, #1202, Kennesaw State University, 1000 Chas-
tain Road, Kennesaw, GA 30144-5591; e-mail: kfle-
isza@kennesaw.edu. Kennesaw State University is an
affirmative action/equal opportunity employer. Women
and minorities are encouraged to apply.
Postdoctoral Fellowship.—This is an opportunity to join
an interdisciplinary team of geneticists, urologists, path-
ologists, and epidemiologists to study genetic risk factors
for prostate cancer development and progression at New
York University Cancer Institute. The project will focus
on the molecular genetic changes that occur in people
from high-risk groups. Experimental approaches include
the use of expression profiling and molecular cytogenetic
analysis and the development of tumor biomarkers for
predicting the malignant potential of lesions. Candidates
must have a Ph.D., D.V.M, M.D., or equivalent degree,
experience in molecular biology and genetics, American
citizenship (or green card), and demonstrated produc-
tivity. The salary is competitive and will be commen-
surate with experience. Full benefits will be provided.
The starting date will be January 1, 2003. A letter of
inquiry, including a curriculum vitae and the names of
three references, should be addressed to Harry Ostrer,
M.D., Human Genetics Program, NYU School of Med-
icine, 550 First Avenue, New York, NY 10016; tele-
phone: (212) 263-7596; fax: (212) 263-3477; e-mail
ostreh01@med.nyu.edu
MEETING
International Meeting on Congenital Disorders of Gly-
cosylation.—An international meeting on the congenital
disorders of glycosylation and related disorders will be
held in Giardini-Naxos, Sicily, April 2–6, 2003. The
meeting will cover all aspects of these disorders, includ-
ing the discovery of novel types, the study of funda-
mental aspects of glycosylation, analytical procedures
and diagnostic methods, and the analysis of models for
the disease. There will be a strong interest in the pre-
sentation of potential therapies. The meeting is organ-
ized by the members of EUROGLYCAN, a European
network for the study of glycan defects, supported by
the European Commission (QLG1-CT2000-00047).
Further information can be obtained by contacting Prof.
Gert Matthijs (the coordinator of EUROGLYCAN) by
e-mail (gert.matthijs@med.kuleuven.ac.be).
CONFERENCE
The Great Lakes Chromosome Conference.—The 41st
annual Great Lakes Chromosome Conference (GLCC)
will be held May 15–16, 2003, in Toronto, Ontario,
Canada. This conference brings together clinical cyto-
geneticists, cytogenetics fellows, and technologists in an
informal setting to examine the themes of cancer cyto-
genetics, clinical problems, research programs, and new
technologies. For additional information, please visit
the conference Web site (http://glccontario.tripod.com/
theGLCC/). If you wish to be added to the conference
e-mail list, please contact meeting organizer Marsha
Speevak (mspeevak@cvh.on.ca).
